Clinical Characteristics and Surgical Outcomes of Full-thickness Macular Hole Without Focal Vitreomacular Traction.
NCT ID: NCT06560710
Last Updated: 2024-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2016-12-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study was to investigate the clinical features and surgical outcomes of FTMHs without focal VMT and to discuss possible underlying mechanisms.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy
NCT02528045
Full Thickness Macular Hole; Should it be Handled Subacutely?
NCT05828251
Evaluation of Anatomic and Visual Outcomes of Initially Closed Macular Holes
NCT01229657
Observation of Recovery of Foveal Cone Microstructures After Macular Hole Surgery
NCT01306487
Comparative Study Between Early Vitrectomy and Observation for Spontaneous Closure of Traumatic Macular Hole
NCT01509092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
macular hole without vitreomacular tracation
Vitrectomy
vitrectimy
Clinical characteristics and surgical outcomes
Stage 2 macular hole with vitreomacular tracation
Vitrectomy
vitrectimy
Clinical characteristics and surgical outcomes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
vitrectimy
Clinical characteristics and surgical outcomes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Stage1.3.4 macular hole
* Macular hole-associated retinal detachment
* Macular hole with subretinal hemorrhage
* Traumatic MH
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Toyama
OTHER
Takaoka city Hospital
UNKNOWN
St. Marianna University School of Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jiro Kogo
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jiro Kogo, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Akita University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MariannaU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.